These two trans fats interfere with how insulin tells blood vessels to relax by blocking key signals in the cell, but other fats don’t have this effect.
Scientific Claim
Elaidic acid and linoelaidic acid impair insulin-mediated phosphorylation of Akt (Ser473) and eNOS (Ser1177) in human endothelial cells, leading to reduced nitric oxide production, while transvaccenic acid and linoleic acid do not, indicating that these industrial trans fats disrupt insulin signaling pathways critical for vascular health.
Original Statement
“Pretreatment with trans-C18:2 (9 trans 12 trans) and trans-C18:1 (trans 9) are associated with impairment of endothelial insulin signaling, however, we did not see an inhibitory effect with trans-C18:1(11 trans) (Transvaccenic acid) or with Linoleic acid (Figure 2A and 2B)... TFA, which are associated with increased NF-κB activation are also associated with reduced endothelial insulin signaling.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The study directly measured phosphorylation of specific signaling proteins (Akt, eNOS) in response to insulin after defined fatty acid exposure. The isomer-specific inhibition is clearly demonstrated and supports definitive language.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bThat dietary intake of elaidic/linoelaidic acids impairs insulin-mediated vasodilation in humans.
That dietary intake of elaidic/linoelaidic acids impairs insulin-mediated vasodilation in humans.
What This Would Prove
That dietary intake of elaidic/linoelaidic acids impairs insulin-mediated vasodilation in humans.
Ideal Study Design
Double-blind RCT of 40 insulin-sensitive adults consuming 3g/day of elaidic acid or placebo for 4 weeks; primary outcome: insulin-mediated brachial artery FMD, secondary: plasma insulin sensitivity (HOMA-IR).
Limitation: Does not assess chronic vascular remodeling or clinical endpoints.
Animal Model StudyLevel 3That chronic exposure to elaidic acid induces endothelial insulin resistance and accelerates atherosclerosis.
That chronic exposure to elaidic acid induces endothelial insulin resistance and accelerates atherosclerosis.
What This Would Prove
That chronic exposure to elaidic acid induces endothelial insulin resistance and accelerates atherosclerosis.
Ideal Study Design
ApoE−/− mice fed 1% elaidic acid vs. control diet for 20 weeks; outcomes: insulin-stimulated aortic eNOS phosphorylation, FMD, and aortic plaque area.
Limitation: Mouse insulin signaling differs from human in key aspects.
Prospective Cohort StudyLevel 2bThat higher plasma elaidic acid levels predict reduced insulin sensitivity and endothelial dysfunction in humans.
That higher plasma elaidic acid levels predict reduced insulin sensitivity and endothelial dysfunction in humans.
What This Would Prove
That higher plasma elaidic acid levels predict reduced insulin sensitivity and endothelial dysfunction in humans.
Ideal Study Design
Cohort of 2,000 adults with plasma trans fat isomers measured at baseline, followed for 5 years with annual HOMA-IR and FMD assessments.
Limitation: Cannot prove causation due to confounding.
Evidence from Studies
Supporting (1)
Trans Fatty Acids Induce Vascular Inflammation and Reduce Vascular Nitric Oxide Production in Endothelial Cells
The study found that certain unhealthy fats from processed foods (elaidic and linoelaidic acids) mess up blood vessel function and reduce nitric oxide, while a similar fat from dairy doesn’t — exactly what the claim says.